Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Proteolytic enzymes may leads to lower acute and late GI toxicity (grade 2+) compared with control (placebo or no intervention) (low certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
It is very uncertain whether summary of findings: Proteolytic enzymes changes diarrhoea (grade 2+) compared with control (placebo or no intervention) (very low certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Glutamine showed no clear difference in acute and late GI toxicity (grade 2+) compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Glutamine showed no clear difference in diarrhoea (grade 2+) compared with placebo (high certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People with urological (prostate) and gynaecological (endometrial) cancer
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Mean GI symptom scores (lower is better) · People undergoing RT for pelvic cancer
Summary of findings: Counselling showed no clear difference in mean GI symptom scores (lower is better) compared with no intervention (low certainty).
1 finding from 1 review
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Counselling may leads to lower diarrhoea (grade 2+) compared with no intervention (low certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
It is very uncertain whether summary of findings: Counselling changes QOL scores (5‐point VAS; lower is better) compared with no intervention (very low certainty).
1 finding from 1 review
QoL · People with urological (prostate) and gynaecological (endometrial) cancer
1 finding from 1 review
Mean GI symptom scores · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Reduced dose volume showed no clear difference in acute and late GI toxicity (grade 2+) compared with standard dose volume (moderate certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean GI symptom scores (during RT) · Men undergoing RT for prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute and late GI toxicity (grade 2+) · Men undergoing RT for prostate cancer
Summary of findings: Higher bladder volume showed no clear difference in acute and late GI toxicity (grade 2+) compared with lower bladder volume (low certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · Men undergoing RT for prostate cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found